← Leaderboards
Gabriela Maria Maron
Arkansas Children'S Hospital Res Inst
$797,595
Attributed
$3,190,378
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,190,378 · 1
By mechanism
R01$3,190,378 · 1
Top collaborators
- Janet A Englund4 shared
- Betsy C. Herold4 shared
- William J Steinbach4 shared
Most similar at Arkansas Children'S Hospital Res Inst
Same institution · by research overlap
- John L Carroll$3,771,000
Others in their field
Other Rising Stars on “Disease Progression”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Angee Greer · Ppd Development Lp$82,531,927
- Mari Ostendorf · University Of Washington$51,931,230
- Sabrina Paganoni · Massachusetts General Hospital$25,017,559
- Suma Babu · Massachusetts General Hospital$25,017,559
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
Research focus
Disease ProgressionDisorder RiskDiagnosticDisease OutcomeAge GroupBiobank2019-NcovAdaptive Immune ResponseAntibody ResponseDiagnostic ProcedureBronchiolitisCase ControlChildChildhoodBiological MarkersCommon ColdCommunicable DiseasesCoronavirusCovid-19BloodBlood SpecimenDetectionDiagnosisEarly Intervention
Grant awards (4)
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$1,502,393
R01 · FY2025 · AI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$1
R01 · FY2024 · AI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$842,739
R01 · FY2023 · AI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$845,245
R01 · FY2022 · AI